TIMP1 and CLDN23 may contribute to adenoma-to-colorectal cancer progression and nominate ruxolitinib for repurposing
Translational Oncology · 2027-01 · 75 · 103116
DOI: 10.1016/j.tranon.2026.103116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Oncology, 2027-01. Verfasst von Penghang Lin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery II, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China; Department of Gastroint…. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery II, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China; Department of Gastrointestinal Surgery, National Regional Medical Center, Binhai Campus of th…
Zitieren
APA
Lin, P., Lin, C., Lin, Y., Liu, S., Ruan, F., Lin, Y., Zhang, S., Liu, Z., Li, W., Li, J., Ye, J., & Zhu, G. (2027). TIMP1 and CLDN23 may contribute to adenoma-to-colorectal cancer progression and nominate ruxolitinib for repurposing. Translational Oncology, 75, 103116. https://doi.org/10.1016/j.tranon.2026.103116
Vancouver
Lin P, Lin C, Lin Y, Liu S, Ruan F, Lin Y, et al. TIMP1 and CLDN23 may contribute to adenoma-to-colorectal cancer progression and nominate ruxolitinib for repurposing. Translational Oncology. 2027;75:103116. doi:10.1016/j.tranon.2026.103116
BibTeX
@article{Lin2027,
author = {Lin, Penghang and Lin, Chunlin and Lin, Yuexin and Liu, Songyi and Ruan, Fangqiu and Lin, Yan and Zhang, Shuyuan and Liu, Zhixiong and Li, Weilong and Li, Jie and Ye, Jianxin and Zhu, Guangwei},
title = {TIMP1 and CLDN23 may contribute to adenoma-to-colorectal cancer progression and nominate ruxolitinib for repurposing},
journal = {Translational Oncology},
year = {2027},
volume = {75},
pages = {103116},
doi = {10.1016/j.tranon.2026.103116}
}
EUVIMED